ORINF (Orion Oyj) Valuation Rank


ORINF Orion Oyj ORINF
100 GF Score
Price $82.75
GF Value $82.46
! 3 Warning Signs
View Full Analysis

What is Orion Oyj Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Orion Oyj Valuation Rank Related Terms

ORINF
100GF Score
Orion Oyj ORINF
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Orion Oyj (ORINF) Overvalued in 2026?

Based on GuruFocus' analysis, Orion Oyj stock appears to be overvalued. The current stock price of $82.75 is trading 0.4% above its estimated GF Value™ of $82.46.

Key valuation signals for ORINF:

  • Valuation Rank:
  • GF Value™: $82.46 vs. price of $82.75 (0.4% above fair value)
  • GF Score™: 100/100 with 3 warning signs

No single metric tells the full story. See the ORINF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Orion Oyj Business Description

Address Orionintie 1, Espoo, FIN, FI-02200
Orion Oyj is a globally operating Finnish pharmaceutical company that develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. The company predominantly focuses on treatments for central nervous system disorders, oncology, and respiratory diseases. Orion's customers include specialists and general practitioners, veterinarians, pharmacies, hospitals, and laboratories. The company mainly serves Finland but also has a presence in other European countries, North America and other countries.
100GF Score

Get the complete analysis for ORINF

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$82.75
Price
$82.46
GF Value